The U.S. House of Representatives Committee on Appropriations’ Subcommittee on Agriculture, Rural Development, and Food and Drug Administration is scheduled to consider an appropriations bill to fund the Department of Agriculture, FDA, and other related agencies for FY2024. The bill includes several provisions that would keep FDA from fulfilling its duty to protect public health and threaten its efforts to combat the harmful impacts of tobacco.
The Florida Department of Health granted more than $1.4 million from the James and Esther King Biomedical Research Program to Taghrid Asfar, a researcher at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, to help construction workers quit smoking.
Vani Simmons, co-director of Moffitt Cancer Center’s Tobacco Research and Intervention Program, received the 2023 American Society of Preventive Oncology’s Joseph W. Cullen Memorial Award. The award will be presented during the ASPO 47th Annual Meeting, March 12-14, in San Diego.
Investigators from Rutgers Cancer Institute of New Jersey found that a higher risk of mortality in Black breast cancer survivors is associated with a history of cigarette smoking along with regular alcohol consumption at the time of diagnosis.
The Independent Expert Panel for Tobacco submitted its recommendations to Commissioner Robert Califf at FDA. The Operational Evaluation of FDA’s Tobacco Program was facilitated by the Reagan-Udall Foundation at the Commissioner’s request.
In April 2022, FDA issued proposed product standards banning menthol flavoring in cigarettes and cigars; however, the benefits of these product standards could be weakened by the role of substitute products still available in the market.
Smoking is still the number one preventable cause of death in the U.S. and lung cancer is far and away the number one cause of cancer death in the U.S.
Roy S. Herbst received an award of appreciation by the SWOG Cancer Research Network for his passion, commitment, leadership, and enduring dedicated service to the ground-breaking Lung-MAP protocol. The award was given at a commemorative dinner during the SWOG Annual Meeting.
To understand the state of affairs with electronic nicotine delivery systems (ENDS), you have to go back to 2006, when ENDS, such as e-cigarettes, became widely available.
FDA issued marketing denial orders for several e-cigarette products currently marketed by Logic Technology Development LLC.
